Trump tariff 'panic': Drug maker Douglas Pharmaceuticals urges incentives not punishment

Trump tariff 'panic': Drug maker Douglas Pharmaceuticals urges incentives not punishment
Douglas Pharmaceuticals is currently developing three drugs. (Image: NZME/Getty/Supplied)
Rebecca Stevenson
A New Zealand pharmaceutical boss says the firm’s manufacture of three drugs could be impacted by the US’s planned 100% tariffs on patented pharmaceuticals. Douglas Pharmaceuticals' managing director, Jeff Douglas, said the proposed tariffs announced by United States President Donald Trump could be devastating for the industry and pose a considerable burden on patients. On Sept 26, Trump said that patented and branded pharmaceutical products would be subject to the tariff starting Oct 1, but drug makers with plans to b...

More Markets

Nvidia slump drags Wall Street and NZ sharemarket lower
Markets Market Close

Nvidia slump drags Wall Street and NZ sharemarket lower

The S&P/NZX 50 Index closed 20 points or 0.15% down at 13,419.40.

Jamie Gray 21 Nov 2025
RBNZ reopens Wellington office after asbestos mayhem
Finance

RBNZ reopens Wellington office after asbestos mayhem

Bank tight-lipped on how many staff are home-working as asbestos-hit office reopens. 

Andy Macdonald 21 Nov 2025
Oceania Healthcare extends dividend freeze
Markets

Oceania Healthcare extends dividend freeze

The retirement village operator hasn't paid a dividend since June 2023.

John Anthony 21 Nov 2025